BioSpace News Archive

Collegium Pharmaceutical, Inc. announced that management will present at the H.C. Wainwright Global Investment Conference being held at the Fontainebleau Miami Beach Hotel from May 23-26, 2022.

JenaValve Technology, Inc. announced the appointment of Kari Moore as the Company’s CFO effective May 10th, 2022.

Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company focused on advancing meaningful therapies for Duchenne muscular dystrophy (Duchenne), today announced that the Company will participate in the following upcoming scientific and patient advocacy conferences.

Madrigal Pharmaceuticals, Inc. announced its management team will participate in two upcoming investor conferences.

Catalyst Pharmaceuticals, Inc. announced that Patrick J. McEnany, Chairman and CEO of Catalyst, along with other members of the management team, will participate at two upcoming conferences.

Merus N.V. announced that Bill Lundberg, M.D., President, Chief Executive Officer of Merus, will present at the H.C. Wainwright Global Investment Conference.

Reflect Scientific, Inc. announces a spring 2022 company overview presentation.

Excision BioTherapeutics Inc., a biotechnology company developing CRISPR-based therapies intended to cure viral infectious diseases, today announced that preclinical and bioinformatic data showing robust and specific editing of HIV proviral DNA with EBT-101 will be featured in an upcoming poster presentation at ASGCT.

Obsidian Therapeutics to Present Significant Advancements to its Proprietary cytoDRiVE® Technology at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting 2022.

Aethlon Medical, Inc., announced that it will be presenting at the H.C. Wainwright Global Investment Conference.